← All trials
NCT03813329
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2004
- Primary completion
- Oct 31, 2004
- Completion date
- Dec 31, 2005
- First posted
- —
- Last posted
- —
- Enrollment
- 10
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Long Island UniversityLead sponsor
- Long Island UniversityReponsible party - principal investigator
- California State University, Los AngelesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.